Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 4, 2009, Pages 588-598

  Kumar, Gollapudi Tarun ^a   Kazim, Syed Naqui ^b   Kumar, Manoj ^a   Hissar, Syed ^a   Chauhan, Ranjit ^a   Basir, Seemi Farhat ^b   Sarin, Shiv Kumar ^a  

^a G B PANT HOSPITAL   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Anti HBc positivity; HBV DNA; Hepatitis B; Occult HBV

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIBODY; METHIONINE; THREONINE; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE TRANSMISSION; DNA EXTRACTION; DNA SEQUENCE; FAMILY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; OCCULT HEPATITIS B VIRUS INFECTION; PHYLOGENETIC TREE CONSTRUCTION METHOD; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; VIRUS GENOME;

EID: 63849280698     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05727.x     Document Type: Article

References (33)

1. Thakur V, Guptan RC, Kazim SN, Malhotra V, Sarin SK. Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian sub continent. J. Gastroenterol. Hepatol. 2000 17 : 165 70.
2. Chaudhari V, Tayal R, Nayak B, Acharya SK, Panda SK. Occult hepatitis B virus infection in chronic liver disease: full - length genome and analysis of mutant surface promoter. Gastroenterology 2004 127 : 1356 71.
3. Yamamoto K, Horikita M, Tsuda F, Itoh k, Akahane Y, Yotsumoto S, Okamato H Hepatitis B virus escapes mutants; 'pushing the envelope' of chronic hepatitis B virus infection. Hepatology 1995 3 : 884 7.
4. Kreutz C. Molecular, immunological and clinical properties of mutated hepatitis B viruses. J. Cell. Mol. Med. 2002 6 : 113 43.
5. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J. Viral Hepat. 2002 9 : 243 57.
6. Damien J, Isabelle C, Bernard M et al. Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assay. J. Med. Virol. 2004 73 : 508 15.
7. Banerjee K, Guptan RC, Bisht R, Sarin SK, Khandekar P. Identification of a novel surface mutant of hepatitis B virus in a seronegative chronic liver disease patient. Virus Res. 1999 65 : 103 9.
8. Guptan RC, Thakur V, Sarin SK, Banerjee K, Khandekar P. Frequency and clinical profile of precore and surface hepatitis B mutants in Asian-Indian patients with chronic liver disease. Am. J. Gastroenterol. 1996 91 : 1312 17.
9. da Sliva C, Lopes Goncales NS, Pereira JS, Escanhoela CAF, Pavan MHP, Junior FLG. The influence of occult infection with hepatitis B virus on liver histology and response to interferon treatment in chronic hepatitis C patients. Braz. J. Infect. Dis. 2004 8 : 431 9.
10. Siagris D, Christofidou M, Triga K, Pagoni N, Theocharis GJ, Goumenos DA. Occult hepatitis B virus infection in hemodialysis patients with chronic HCV infection. J. Nephrol. 2006 19 : 327 33.
11. Cacciola I, Pollicino T, Savadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N. Engl. J. Med. 1999 34 : 22 6.
12. Chemin I, Zoulim F, Merle P et al. High incidence of hepatitis B infections among chronic hepatitis cases on unknown aetiology. J. Hepatol. 2001 34 : 447 54.
13. Kao JH, Chen PJ, Lai MY, Chen DS. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J. Clin. Microbiol. 2002 40 : 4068 71.
14. Khattab E, Chemin I, Vuillermoz I et al. Analysis of HCV co - infection with occult hepatitis B virus in patients undergoing IFN therapy. J. Clin. Virol. 2005 33 : 150 7.
15. Tamori A, Nishiguchi S, Kubo S et al. Sequencing of human - viral DNA junctions in hepatocellular carcinoma from patients with HCV and occult HBV infection. J. Med. Virol. 2003 69 : 475 81.
16. Schaefer S. Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J. Gastroenterol. 2007 13 : 14 21.
17. Norder H, Courouce AM, Coursaget P et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes and HBsAg subtypes. Intervirology 2004 47 : 289 309.
18. Vivekanandan P, Abraham P, Sridharan G et al. Distribution of Hepatitis B virus genotypes in blood donors and chronically infected patients in a tertiary care hospital in southern India. Clin. Infect. Dis. 2004 38 : e81 6.
19. Banerjee A, Banerjee S, Chowdhury A et al. Nucleic acid sequence analysis of basal core promoter/precore/core region of hepatitis B virus isolated from chronic carriers of the virus from kolkata, eastern India: low frequency of mutation in the precore region. Intervirology 2005 48 : 389 99.
20. Datta S, Banerjee A, Chandra PK, Chowdhary A, Chakravarty R. Genotype, phylogenic analysis, and transmission pattern of occult Hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers. J. Med. Virol. 2006 78 : 53 9.
21. Wakil SM, Kazim SN, Khan LA et al. Prevalence and profile of mutations associated with lamuvidine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus. J. Med. Virol. 2002 68 : 311 18.
22. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981 1 : 431 35.
23. Goodman ZD, Ishak KG. Histopathology of hepatitis C virus infection. Semin. Liver Dis. 1995 15 : 70 81.
24. Corpet F. Multiple sequence alignment with heirarchical clustering. Nucl. Acids Res. 1988 16 : 10881 90.
25. Torresi J, Earnest-Silveira L, Deliyannis G et al. Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase genes that are selected by lamivudine therapy. Virology 2002 293 : 305 13.
26. Chiou HL, Lee TS, Kuo J, Mav YC, Hom S. Altered antigenicity of 'a' determinant variants of hepatitis B virus. J. Gen. Virol. 1997 78 : 2639 45.
27. Shiota G, Oyama K, Udagawa A et al. Occult hepatitis B virus infection in HBs antigen - negative hepatocellular carcinoma in a Japanese population; involvement of HBx and P53. J. Med. Virol. 2000 62 : 151 8.
28. Pollicino T, Sauadrito G, Cezenzia G. Hepatitis B Virus (HBV) maintains its pro - oncogenic properties in case of occult HBV infection. Gastroenterology 2004 126 : 102 10.
29. Minuk GY, Sun D-F, Uhanova J et al. Occult hepatitis B virus infection in a North American community - based population. J. Hepatol. 2005 42 : 480 5.
30. Cortelezzi A, Vigano M, Zilioli VR et al. Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-Cell chronic lymphocytic leukemia on prolonged therapy with campath - 1H. J. Clin. Virol. 2006 35 : 467 9.
31. Banerjee A, Kurbanov F, Datta S et al. Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India. J. Med. Virol. 2006 78 : 1164 74.
32. Kazim SN, Sarin SK, Sharma BC, Khan LA, Hasnain SE. Characterization of naturally occurring and Lamivudine-induced surface gene mutants of hepatitis B virus in patients with chronic hepatitis B in India. Intervirology 2006 49 : 152 60.
33. Thakur V, Kazim SN, Guptan RC, Malhotra V, Sarin SK. Molecular epidemiology and transmission of hepatitis B virus in close family contacts of HBV-related chronic liver disease patients. J. Med. Virol. 2003 70 : 520 8.